Consolidating firms can't forget technology

Article

Consolidating firms can't forget technologyAny vendor participating in the PACS market knows that it is being reshaped by the forces of consolidation. Driven by the desire to maximize distribution channels or to provide the right product mix to

Consolidating firms can't forget technology

Any vendor participating in the PACS market knows that it is being reshaped by the forces of consolidation. Driven by the desire to maximize distribution channels or to provide the right product mix to customers, Kodak and Imation, Medasys and Citation, and HBO and Imnet have decided in the last month to tie their respective companies' futures together.

Whether their strategies will prove successful is, of course, too early to tell. But with customers increasingly searching for complete, one-stop shopping for their PACS and healthcare-information technology needs, consolidation moves can only benefit these companies as they strive for a more prominent market presence.

Despite many valiant efforts, only a few small firms have been able to carve out a lasting niche for themselves in PACS. The rest have either been acquired by larger companies seeking to fill out their product line, or have simply exited the business for greener pastures.

Although the marketing message of these mergers and acquisitions can be powerful, ultimately it is the success these companies achieve in integrating their technologies that will dictate their fates. The history of the PACS market is replete with corporate marriages that failed to live up to the promises proclaimed in their press releases. As several vendors in this sector have found, slick advertising and marketing campaigns won't amount to much if the corresponding products fail to measure up to customer expectations. It's a lesson that has often been forgotten in the PACS market.

-Erik L. Ridley, Editor

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.